CarlosR.SalamaMD

HIV/AIDS Medicine

Associate Professor, Medicine, Icahn School of Medicine

Dr. Salama is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
7901 Broadway
Room A1-9
Elmhurst, NY 11373
Phone+1 718-334-4952

Fax+1 718-334-4815

Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1995 - 1997
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1992 - 1995
Icahn School of Medicine at Mount SinaiClass of 1992

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016

PubMed

Too much of a good thing: Immune reconstitution inflammatory syndrome in a patient with Still's disease.
Nuzhat Batool, David Song, Talal Almas, Abdulla K Alsubai, Tushar Thakur
Annals of Medicine and Surgery. 2022-10-01
7 citations
HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak.
Emma Kaplan-Lewis, Jaspreet Banga, Maria R. Khan, Eunice Casey, Medha Mazumdar
AIDS Patient Care and Stds. 2021-11-15
478 citations
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
Carlos Salama, Jian Han, Linda Yau, William G Reiss, Benjamin Kramer
The New England Journal of Medicine. 2021-01-07

How COVID-19 Is Shifting the Way We Conduct Clinical TrialsNovember 11th, 2022
RA Biologic Tocilizumab Shows Promise in Covid-19 PneumoniaDecember 18th, 2020
Tocilizumab May Lower Risk for COVID-19 Progression, but Not MortalityDecember 17th, 2020